Stay updated on Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedA new revision entry labeled v3.5.5 was added to the history, and the previous v3.5.4 entry was removed from the listing, reflecting an update to the record.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry v3.5.4 has been added to the study's record history, replacing the previous v3.5.3 entry. This reflects a minor update to the page's version metadata and does not affect study content or results.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page’s interface/version indicator updates from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a software/UI revision rather than any substantive update to the clinical trial information.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.5.2 was added to the history and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision v3.5.0 was added to the history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history list. This update only changes version labels in the history section and does not modify study data or page content.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.